Cadernos de Saúde Pública
Print version ISSN 0102-311X
DREYER, Gerusa and COELHO, Giovanini. Lymphatic filariasis: a potentially eradicable disease. Cad. Saúde Pública [online]. 1997, vol.13, n.3, pp. 537-543. ISSN 0102-311X. http://dx.doi.org/10.1590/S0102-311X1997000300030.
The recent demonstration that single-dose ivermectin, diethylcarbamazine, or a combination of these drugs can profoundly suppress Wuchereria bancrofti and Brugia malayi microfilaremia for periods of six months to two years has led to renewed hope that transmission can be interrupted and lymphatic filariasis eradicated. Based in part on the availability of these new chemotherapeutic tools, the International Task Force for Disease Eradication recently identified lymphatic filariasis as one of the few diseases that could potentially be eradicated. Thus, control programs based on mass treatment (whether supplemented or not by vector control) have begun to be implemented in some endemic areas. We provide a brief review of available anti-filarial drugs for use in humans, including their tolerance and efficacy.
Keywords : Lymphatic Filariosis; Control; Ivermectin; Diethylcarbamazine; Wuchereria bancrofti.